Ananthi J, Prakasam A, Pugalendi K V
Department of Biochemistry, Faculty of Science, Annamalai University, Annamalainagar 608 002, Tamilnadu, India.
Yale J Biol Med. 2003;76(3):97-102.
Eclipta alba, an indigenous medicinal plant, has a folk (Siddha and Ayurvedha) reputation in rural southern India as a hypoglycemic agent. In order to confirm this claim, the present study was carried out to evaluate the antihyperglycemic effect of E. alba and to study the activities of liver hexokinase and gluconeogenic enzymes such as glucose-6-phosphatase and fructose 1,6-bisphosphatase in the liver of control and alloxan-diabetic rats. Oral administration of leaf suspension of E. alba (2 and 4 g/kg body weight) for 60 days resulted in significant reduction in blood glucose (from 372.0 +/- 33.2 to 117.0 +/- 22.8), glycosylated hemoglobin HbA(1)c, a decrease in the activities of glucose-6 phosphatase and fructose 1,6-bisphosphatase, and an increase in the activity of liver hexokinase. E. alba at dose of 2 g/kg body weight exhibited better sugar reduction than 4 g/kg body weight. Thus, the present study clearly shows that the oral administration of E. alba possess potent antihyperglycemic activity.
白花蟛蜞菊是一种本土药用植物,在印度南部农村地区的民间(悉达和阿育吠陀医学)中享有降血糖药物的声誉。为了证实这一说法,本研究旨在评估白花蟛蜞菊的降血糖作用,并研究正常大鼠和四氧嘧啶诱导的糖尿病大鼠肝脏中己糖激酶以及糖异生酶如葡萄糖-6-磷酸酶和果糖1,6-二磷酸酶的活性。口服白花蟛蜞菊叶悬液(2和4克/千克体重)60天可使血糖显著降低(从372.0±33.2降至117.0±22.8),糖化血红蛋白HbA1c降低,葡萄糖-6-磷酸酶和果糖1,6-二磷酸酶的活性降低,肝脏己糖激酶的活性增加。2克/千克体重剂量的白花蟛蜞菊比4克/千克体重剂量表现出更好的降糖效果。因此,本研究清楚地表明口服白花蟛蜞菊具有强大的降血糖活性。